The curious case of the HepG2 cell line: 40 years of expertise

VA Arzumanian, OI Kiseleva… - International journal of …, 2021 - mdpi.com
Liver cancer is the third leading cause of cancer death worldwide. Representing such a
dramatic impact on our lives, liver cancer is a significant public health concern. Sustainable …

[HTML][HTML] The evolving role of investigative toxicology in the pharmaceutical industry

F Pognan, M Beilmann, H Boonen, A Czich… - Nature reviews drug …, 2023 - nature.com
For decades, preclinical toxicology was essentially a descriptive discipline in which
treatment-related effects were carefully reported and used as a basis to calculate safety …

3D bioprinted liver tissue and disease models: Current advances and future perspectives

L Sun, Y Wang, S Zhang, H Yang, Y Mao - Biomaterials Advances, 2023 - Elsevier
Abstract Three-dimensional (3D) bioprinting is a promising technology for fabricating
complex tissue constructs with biomimetic biological functions and stable mechanical …

[HTML][HTML] Organ-specific endothelial cell heterogenicity and its impact on regenerative medicine and biomedical engineering applications

M Urbanczyk, A Zbinden, K Schenke-Layland - Advanced Drug Delivery …, 2022 - Elsevier
Endothelial cells (ECs) are a key cellular component of the vascular system as they form the
inner lining of the blood vessels. Recent findings highlight that ECs express extensive …

Organotypic and microphysiological human tissue models for drug discovery and development—current state-of-the-art and future perspectives

S Youhanna, AM Kemas, L Preiss, Y Zhou… - Pharmacological …, 2022 - ASPET
The number of successful drug development projects has been stagnant for decades
despite major breakthroughs in chemistry, molecular biology, and genetics. Unreliable target …

Modelling urea cycle disorders using iPSCs

C Duff, J Baruteau - npj Regenerative Medicine, 2022 - nature.com
The urea cycle is a liver-based pathway enabling disposal of nitrogen waste. Urea cycle
disorders (UCDs) are inherited metabolic diseases caused by deficiency of enzymes or …

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and HCC

A Smiriglia, N Lorito, M Serra, A Perra, A Morandi… - Iscience, 2023 - cell.com
Only a few preclinical findings are confirmed in the clinic, posing a critical issue for clinical
development. Therefore, identifying the best preclinical models can help dissect molecular …

On-microparticle construction of endothelialized liver microtissues for drug testing

Z Wu, Y Zheng, JM Lin, Y Li, Y Lin, X Wang… - Chemical Engineering …, 2024 - Elsevier
With the advantage of uniformity and customizability, hydrogel microparticles are widely
used to establish in vitro organoid modeling for drug testing. However, the practical values of …

Mapping interindividual variability of toxicodynamics using high-throughput transcriptomics and primary human hepatocytes from fifty donors

M Niemeijer, W Więcek, S Fu… - Environmental …, 2024 - ehp.niehs.nih.gov
Background: Understanding the variability across the human population with respect to
toxicodynamic responses after exposure to chemicals, such as environmental toxicants or …

[HTML][HTML] Multi-tissue proteogenomic analysis for mechanistic toxicology studies in non-model species

MS Lin, MS Varunjikar, KK Lie, L Søfteland… - Environment …, 2023 - Elsevier
New approach methodologies (NAM), including omics and in vitro approaches, are
contributing to the implementation of 3R (reduction, refinement and replacement) strategies …